HomeCompareNVRO vs O

NVRO vs O: Dividend Comparison 2026

NVRO yields 34.25% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVRO wins by $134.4K in total portfolio value
10 years
NVRO
NVRO
● Live price
34.25%
Share price
$5.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$168.6K
Annual income
$25,000.88
Full NVRO calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — NVRO vs O

📍 NVRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVROO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVRO + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVRO pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVRO
Annual income on $10K today (after 15% tax)
$2,910.96/yr
After 10yr DRIP, annual income (after tax)
$21,250.75/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, NVRO beats the other by $16,913.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVRO + O for your $10,000?

NVRO: 50%O: 50%
100% O50/50100% NVRO
Portfolio after 10yr
$101.4K
Annual income
$15,051.81/yr
Blended yield
14.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

NVRO
Analyst Ratings
9
Buy
19
Hold
4
Sell
Consensus: Hold
Price Target
$30.32
+419.2% upside vs current
Range: $4.00 — $125.00
Altman Z
-0.6
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVRO buys
0
O buys
0
No recent congressional trades found for NVRO or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVROO
Forward yield34.25%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$168.6K$34.2K
Annual income after 10y$25,000.88$5,102.74
Total dividends collected$120.7K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$30.32$64.00

Year-by-year: NVRO vs O ($10,000, DRIP)

YearNVRO PortfolioNVRO Income/yrO PortfolioO Income/yrGap
1← crossover$14,125$3,424.66$10,818$608.16+$3.3KNVRO
2$19,634$4,520.76$11,787$741.68+$7.8KNVRO
3$26,882$5,873.02$12,946$911.00+$13.9KNVRO
4$36,278$7,514.85$14,345$1,127.94+$21.9KNVRO
5$48,296$9,478.22$16,056$1,409.05+$32.2KNVRO
6$63,469$11,792.55$18,171$1,777.83+$45.3KNVRO
7$82,395$14,483.60$20,820$2,268.21+$61.6KNVRO
8$105,736$17,572.52$24,188$2,929.90+$81.5KNVRO
9$134,212$21,075.04$28,533$3,837.11+$105.7KNVRO
10$168,608$25,000.88$34,235$5,102.74+$134.4KNVRO

NVRO vs O: Complete Analysis 2026

NVROStock

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Full NVRO Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this NVRO vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVRO vs SCHDNVRO vs JEPINVRO vs KONVRO vs MAINNVRO vs STAGNVRO vs ADCNVRO vs NNNNVRO vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.